Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/31/2001EP1149905A1 Methods and compositions for polypeptide engineering
10/31/2001EP1149904A1 Methods and compositions for polypeptide engineering
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149844A2 Truncated reelin protein and DNA encoding the same
10/31/2001EP1149843A1 Substituted phenethylamine derivatives
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149590A1 Use of gut peptide antibodies to improve feed efficiency
10/31/2001EP1149586A1 Bidirectional modulation of immunity
10/31/2001EP1149585A1 Use of recombinant gastric lipase for treating functional dyspepsia
10/31/2001EP1149583A2 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
10/31/2001EP1149582A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Uses thereof
10/31/2001EP1149171A1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof
10/31/2001EP1149169A1 Methods of use of a novel lysyl oxidase-related protein
10/31/2001EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001EP1149167A2 Viral vaccine
10/31/2001EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
10/31/2001EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149112A2 Ewing's tumour antigen, nucleic acid and antibodies
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148897A1 Methods and compositions for healing and repair of articular cartilage
10/31/2001EP1148889A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
10/31/2001EP1148888A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
10/31/2001EP1148887A2 Regulation of anaesthesia
10/31/2001EP1148791A1 Protein material for slow digestion and its use
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001EP1001799B1 Pharmaceutical composition containing peptichemio
10/31/2001EP0902780B1 Quaternary cytofectins
10/31/2001EP0833652A4 Novel kappa receptor selective opioid peptides
10/31/2001EP0775159B1 Novel process for the production of biologically active dimeric protein
10/31/2001EP0775157B1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
10/31/2001EP0723454B1 Novel tripeptides useful in immune and cns therapy
10/31/2001EP0719154B1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency
10/31/2001EP0703779B1 Enzyme-containing tablets and process of preparation thereof
10/31/2001EP0613376B1 Use of igf-1
10/31/2001EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10020138A1 Nukleinsäure codierend für zumindest eine raf Teilsequenz mit einer MEKK1 Bindungsstelle Nucleic acid coding for at least a part of raf sequence with a MEKK1 binding site
10/31/2001DE10019252A1 Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression Polydeoxyribonucleotides to inhibit the ICAM-1 gene expression
10/31/2001DE10019135A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320164A Novel collectin
10/31/2001CN1320163A Method for triggering apoptosis in cells
10/31/2001CN1320045A Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
10/31/2001CN1320044A Combination therapies for B-cell lymphomas comprising administration of anti-CD 20 antibody
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320041A Treatment of hepatitis B infection with thymosin alpha 1 and lamivudine
10/31/2001CN1320040A Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
10/31/2001CN1320032A Alginate capsules for use in the treatment of brain tumor
10/31/2001CN1319664A Novel polypeptide--human glocosamine-6-phosphoisomerase 12 and polynucleotide for encoding said polypeptide
10/31/2001CN1319662A Human testicular ubiquitin specific proteinase-10 gene coding protein
10/31/2001CN1319661A Novel polypeptide--human ATP dependent uncoiling enzyme 31 and polynucleotide for encoding said polypeptide
10/31/2001CN1319660A Human testis specific protein kinase gene coding protein
10/31/2001CN1319659A Novel polypeptide-human lysyloxidase 33 and polynucleotide for encoding said polypeptide
10/31/2001CN1319658A Novel polypeptide--D-isomer specific 2-hydroxy acid dehydrogenase 30 and polynucleotide for encoding said polypeptide
10/31/2001CN1319656A Novel polypeptide--ATP-specific succinyl coenzyme A synthetase 51 and polynucleotide for encoding said polypeptide
10/31/2001CN1319655A Novel polypeptide-DNA polymerase III 12 and polynucleotide for encoding said polypeptide
10/31/2001CN1319612A Novel polypeptide-human scorpion short chain toxin protein 9 and polynucleotide for encoding said polypeptide
10/31/2001CN1319610A Novel polypeptide-human corticotrophin releasing factor 23 and polynucleotide for encoding said polypeptide
10/31/2001CN1319609A Novel polypeptide-human kinesin 9 and polynucleoitde for encoding said polypeptide
10/31/2001CN1319606A Novel polypeptide-human actin formation regulator 30 and polynucleotide for encoding said polypeptide
10/31/2001CN1319605A Antitumour polypeptide and gene therapy vector composition
10/31/2001CN1319400A Epiderm specificity transfer factor
10/31/2001CN1073856C Injection for emetic action and clearing stomach
10/31/2001CN1073814C Bitersguash extract sugar-reducing milk power and its preparation process
10/30/2001US6310193 Nucleotide sequences for use in the detection of microorganism; for use in screening bactericides
10/30/2001US6310192 SigB
10/30/2001US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis
10/30/2001US6310183 Treatment blood disorders; generate blood coagulation factor and inject into human, monitor for adjustment in condition
10/30/2001US6310182 Polypeptide for use in treatment of intracellular vesicular defects
10/30/2001US6310180 Method for synthesis of proteins
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310176 Antimicrobially active polypeptides
10/30/2001US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001US6310057 α-ketoamide multicatalytic protease inhibitors
10/30/2001US6310046 Encoded by isolated dna; diagnosis of and immunization against malaria
10/30/2001US6310045 Compositions and methods for cancer immunotherapy
10/30/2001US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses
10/30/2001US6310041 For treatment of eye disease selected from alkali-injured eye, chemically injured eye and inflammatory disease of the eye
10/30/2001US6310040 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
10/30/2001US6310039 Tumor-inhibiting conjugates of proteins and polymers consisting of a suitable carrier system and cytostatic compounds
10/30/2001US6310038 Pulmonary insulin crystals
10/30/2001US6310037 Method of controlling protozoan infections using syringomycin-family lipodepsipeptides
10/30/2001US6310036 Comprising at least one fibrous protein, at least one globular protein, and at least one cross-linking agent, wherein proteins are ultrasonically treated prior to application to a mammal tissue
10/30/2001US6309882 An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid encoding the human replication protein a p70 subunit, and inhibits the expression of the human replication protein a p70 subunit
10/30/2001US6309880 Antibodies specific for CD4-binding domain of HIV-1
10/30/2001US6309877 Polynucleotides encoding motoneuronotrophic factors
10/30/2001US6309873 Streptokinase mutants
10/30/2001US6309867 Polypeptide; for use in controlling aging and cancer
10/30/2001US6309866 6-phosphogluconate dehydrogenase
10/30/2001US6309860 Cloning and uses of BCL-8
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309855 Nucleotide sequences coding transport protein; for use in detecting modulators in ionic mobility
10/30/2001US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/30/2001US6309853 Nucleotide sequences coding polypeptide associated with contolling bdy weight; for use in diagnosis and treatment of eating disorders
10/30/2001US6309849 Detecting modulators of enzymatic activities; incubate enzyme with modulator, monitor enzyme for binding activity
10/30/2001US6309826 Diagnosing tumors; monitor tumorous tissue for nucleotide sequences coding tumor glycoprotein, compare to amount of nucleotide sequences coding tumor glycoprotein in healthy sample, classify cells
1 ... 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 ... 3163